GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Feb 2022 01:26 PM
RNS
Transfer of Treasury Shares
11 Feb 2022 02:06 PM
RNS
Director/PDMR Shareholding
11 Feb 2022 09:33 AM
RNS
Director/PDMR Shareholding
10 Feb 2022 09:00 AM
RNS
Benlysta approved in China for Lupus Nephritis
09 Feb 2022 11:07 AM
RNS
Director/PDMR Shareholding
09 Feb 2022 07:00 AM
RNS
Final Results
07 Feb 2022 10:30 AM
RNS
Publication of full year 2021 results: Replacement
07 Feb 2022 10:00 AM
RNS
Publication of full year 2021 results
02 Feb 2022 07:00 AM
RNS
GSK announces settlement between ViiV and Gilead
01 Feb 2022 01:44 PM
RNS
FDA approves ViiV Healthcare's sNDA for Cabenuva
01 Feb 2022 11:44 AM
RNS
Total Voting Rights
26 Jan 2022 04:48 PM
RNS
Director/PDMR Shareholding
20 Jan 2022 03:59 PM
RNS
Director/PDMR Shareholding
19 Jan 2022 04:33 PM
RNS
Director/PDMR Shareholding
19 Jan 2022 03:14 PM
RNS
Director/PDMR Shareholding
19 Jan 2022 03:10 PM
RNS
Director/PDMR Shareholding
19 Jan 2022 07:00 AM
RNS
Tony Wood appointed CSO Designate, GSK
17 Jan 2022 05:04 PM
RNS
Director/PDMR Shareholding
17 Jan 2022 03:07 PM
RNS
Director/PDMR Shareholding
17 Jan 2022 07:00 AM
RNS
Update - GSK Consumer Healthcare
14 Jan 2022 03:22 PM
RNS
Director/PDMR Shareholding
13 Jan 2022 04:12 PM
RNS
Director/PDMR Shareholding
11 Jan 2022 04:28 PM
RNS
Director/PDMR Shareholding
11 Jan 2022 12:08 PM
RNS
US Govt buys additional 600,000 sotrovimab doses
04 Jan 2022 12:28 PM
RNS
Total Voting Rights
23 Dec 2021 01:11 PM
RNS
Director/PDMR Shareholding
22 Dec 2021 02:57 PM
RNS
Director/PDMR Shareholding
21 Dec 2021 07:00 AM
RNS
ViiV Healthcare announces FDA approval of Apretude
20 Dec 2021 07:00 AM
RNS
Consumer Healthcare Chair Designate appointed
17 Dec 2021 12:48 PM
RNS
Xevudy approved in Europe to treat COVID-19
15 Dec 2021 07:00 AM
RNS
GSK/Sanofi COVID-19 vaccine booster & Ph3 update
13 Dec 2021 11:25 AM
RNS
Director/PDMR Shareholding
09 Dec 2021 04:35 PM
RNS
Director/PDMR Shareholding
07 Dec 2021 12:00 PM
RNS
Medicago/GSK COVID-19 vaccine positive Ph3 data
07 Dec 2021 07:07 AM
RNS
Sotrovimab retains its activity vs Omicron variant
02 Dec 2021 07:02 AM
RNS
Sotrovimab retains its activity vs Omicron variant
01 Dec 2021 11:05 AM
PRN
Total Voting Rights
24 Nov 2021 04:17 PM
RNS
Director/PDMR Shareholding
24 Nov 2021 04:00 PM
RNS
GSK publishes provisional 2022 dividend dates
23 Nov 2021 03:06 PM
RNS
Director/PDMR Shareholding
17 Nov 2021 07:00 AM
RNS
Nucala approved in Europe for more indications
15 Nov 2021 04:37 PM
RNS
Block listing Interim Review
12 Nov 2021 12:00 PM
RNS
Phase III IM administration data for sotrovimab
12 Nov 2021 09:23 AM
RNS
Director/PDMR Shareholding
10 Nov 2021 11:28 AM
RNS
Director/PDMR Shareholding
05 Nov 2021 05:33 PM
RNS
GSK shares positive Phase III data for daprodustat
01 Nov 2021 05:11 PM
RNS
Total Voting Rights
27 Oct 2021 02:23 PM
RNS
Director/PDMR Shareholding
27 Oct 2021 12:00 PM
RNS
3rd Quarter Results
27 Oct 2021 09:00 AM
RNS
Directorate Change

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings